72 related articles for article (PubMed ID: 9118459)
41. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
Braakhuis BJ; Hill BT; Dietel M; Kelland LR; Aapro MS; Zoli W; Lelieveld P
Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419
[TBL] [Abstract][Full Text] [Related]
42. Antitumor activity of paclitaxel (taxol) analogues on MDR-positive human cancer cells.
Distefano M; Scambia G; Ferlini C; Gallo D; De Vincenzo R; Filippini P; Riva A; Bombardelli E; Mancuso S
Anticancer Drug Des; 1998 Jul; 13(5):489-99. PubMed ID: 9702212
[TBL] [Abstract][Full Text] [Related]
43. Preclinical in vivo efficacy of two 9-dihydrotaxane analogues against human and murine tumours.
Alder JD; Jarvis KP; Marsh KC; Klein LL; Clement JJ
Br J Cancer; 1996 Mar; 73(5):560-4. PubMed ID: 8605087
[TBL] [Abstract][Full Text] [Related]
44. Carrier effects on antitumor activity and neurotoxicity of AZ10992, a paclitaxel-carboxymethyl dextran conjugate, in a mouse model.
Sugahara S; Kajiki M; Kuriyama H; Kobayashi TR
Biol Pharm Bull; 2008 Feb; 31(2):223-30. PubMed ID: 18239277
[TBL] [Abstract][Full Text] [Related]
45. The use of a novel taxane-based P-glycoprotein inhibitor to identify mutations that alter the interaction of the protein with paclitaxel.
Gruol DJ; Bernd J; Phippard AE; Ojima I; Bernacki RJ
Mol Pharmacol; 2001 Jul; 60(1):104-13. PubMed ID: 11408605
[TBL] [Abstract][Full Text] [Related]
46. Antitumor activity of 9(R)-dihydrotaxane analogs.
Klein LL; Li L; Maring CJ; Yeung CM; Thomas SA; Grampovnik DJ; Plattner JJ
J Med Chem; 1995 Apr; 38(9):1482-92. PubMed ID: 7739007
[TBL] [Abstract][Full Text] [Related]
47. Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human feces.
Sparreboom A; Huizing MT; Boesen JJ; Nooijen WJ; van Tellingen O; Beijnen JH
Cancer Chemother Pharmacol; 1995; 36(4):299-304. PubMed ID: 7628049
[TBL] [Abstract][Full Text] [Related]
48. Design and synthesis of a water-soluble taxol analogue: taxol-sialyl conjugate.
Takahashi T; Tsukamoto H; Yamada H
Bioorg Med Chem Lett; 1998 Jan; 8(1):113-6. PubMed ID: 9925441
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and evaluation of paclitaxel C7 derivatives: solution phase synthesis of combinatorial libraries.
Bhat L; Liu Y; Victory SF; Himes RH; Georg GI
Bioorg Med Chem Lett; 1998 Nov; 8(22):3181-6. PubMed ID: 9873699
[TBL] [Abstract][Full Text] [Related]
50. The rat spermatogenesis after injection of paclitaxel (antitumor agent).
Borovskaya TG; Goldberg VE; Rumpel OA; Pahomova AV; Perova AV; Goldberg ED
Bull Exp Biol Med; 2009 Jun; 147(6):715-8. PubMed ID: 19902065
[TBL] [Abstract][Full Text] [Related]
51. THE RELATIVE REACTION WITHIN LIVING MAMMALIAN TISSUES : V. (a) INFLUENCE OF LYMPH-SOLUBLE TISSUE MATERIALS ON THE SIGNIFICANCE OF THE COLORATION WITH SOME PHTHALEIN INDICATORS.
Drury DR; Rous P
J Exp Med; 1926 Apr; 43(5):669-86. PubMed ID: 19869152
[TBL] [Abstract][Full Text] [Related]
52. [Pharmacodynamic action of a new water-soluble derivative of dioxistylbene (hydroestril)].
GOISIS M
Boll Soc Ital Biol Sper; 1947 Apr; 23(3):219. PubMed ID: 18919590
[No Abstract] [Full Text] [Related]
53. 2'-Behenoyl-paclitaxel conjugate containing lipid nanoparticles for the treatment of metastatic breast cancer.
Ma P; Rahima Benhabbour S; Feng L; Mumper RJ
Cancer Lett; 2013 Jul; 334(2):253-62. PubMed ID: 22902506
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide-paclitaxel conjugate in mice with breast cancer.
Cao Q; Li ZB; Chen K; Wu Z; He L; Neamati N; Chen X
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1489-98. PubMed ID: 18373091
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and applications of hyaluronic acid-paclitaxel bioconjugates.
Leonelli F; La Bella A; Migneco LM; Bettolo RM
Molecules; 2008 Feb; 13(2):360-78. PubMed ID: 18305424
[TBL] [Abstract][Full Text] [Related]
56. A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug.
Stevens PJ; Sekido M; Lee RJ
Pharm Res; 2004 Dec; 21(12):2153-7. PubMed ID: 15648245
[TBL] [Abstract][Full Text] [Related]
57. A differential scanning calorimetry study of phosphocholines mixed with paclitaxel and its bromoacylated taxanes.
Ali S; Minchey S; Janoff A; Mayhew E
Biophys J; 2000 Jan; 78(1):246-56. PubMed ID: 10620289
[TBL] [Abstract][Full Text] [Related]
58. Preclinical antitumor activity of water-soluble paclitaxel derivatives.
Rose WC; Clark JL; Lee FY; Casazza AM
Cancer Chemother Pharmacol; 1997; 39(6):486-92. PubMed ID: 9118459
[TBL] [Abstract][Full Text] [Related]
59. Preclinical oral antitumor activity of BMS-185660, a paclitaxel derivative.
Rose WC; Lee FY; Golik J; Kadow J
Cancer Chemother Pharmacol; 2000; 46(3):246-50. PubMed ID: 11021743
[TBL] [Abstract][Full Text] [Related]
60. Preclinical antitumor activity of orally administered platinum (IV) complexes.
Rose WC; Crosswell AR; Schurig JE; Casazza AM
Cancer Chemother Pharmacol; 1993; 32(3):197-203. PubMed ID: 8500224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
